Clinical uses of GM-CSF, a critical appraisal and update
Martha Arellano, Sagar LonialEmory University, Winship Cancer Institute, Atlanta, GA, USAAbstract: The role of granulocyte-macrophage-colony-stimulating factor (GM-CSF) in the supportive care of cancer patients has been evaluated with promising results. More recently, GM-CSF has been added to regime...
Guardado en:
Autores principales: | Martha Arellano, Sagar Lonial |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/32953b4d00e0411a88651813463f32b8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Emerging treatments in Castleman disease – a critical appraisal of siltuximab
por: Koff JL, et al.
Publicado: (2016) -
Critical appraisal of axitinib in the treatment of advanced renal cell carcinoma
por: Ansari J, et al.
Publicado: (2013) -
Critical appraisal of canakinumab in the treatment of adults and children with cryopyrin-associated periodic syndrome (CAPS)
por: Ori Toker, et al.
Publicado: (2010) -
Targeted treatment of psoriasis with adalimumab: a critical appraisal based on a systematic review of the literature
por: Jochen Schmitt, et al.
Publicado: (2009) -
DIRECT EFFECTS OF GM-CSF ON THE FUNCTIONS OF HUMAN MONOCYTES/MACROPHAGES
por: N. D. Gazatova, et al.
Publicado: (2019)